Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

21.11.17	Ontario Nurses' Association Welcomes New Members (PR Newswire)
20.11.17	Lilly Confirms Date and Conference Call for 2018 Financial Guidance Announcement (PR Newswire)
17.11.17	Lilly to Participate in Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference (PR Newswire)
14.11.17	Le Cercle finance et placement du Québec reçoit Arjang Roshan, Président et chef de la direction chez 5N PLUS (PR Newswire)
14.11.17	FDA Nod For AGN, ZYME Strikes A Deal With Janssen Biotech, TCON Abuzz (RTTNews)
14.11.17	Lilly: Jardiance Reduces Risk Of Cardiovascular Death In Type 2 Diabetes And PAD (RTTNews)
14.11.17	Jardiance® reduced risk of cardiovascular death in adults with type 2 diabetes and peripheral artery disease (PR Newswire)
13.11.17	Lilly Appoints Philip Johnson to Senior Vice President and Treasurer (PR Newswire)
10.11.17	Elanco, Aratana Announce Positive Opinion on GALLIPRANT® (grapiprant tablets) in Europe (PR Newswire)
10.11.17	New Data on FORTEO® (teriparatide [rDNA origin] injection) Showed Reduced Risk for New Vertebral and Clinical Fractures in Postmenopausal Women with Severe Osteoporosis (PR Newswire)
08.11.17	ACR/ARHP 2017: Long-Term Use of Lilly's Taltz® (ixekizumab) Shows Efficacy Improvements in Psoriatic Arthritis for Patients with Prior Inadequate Response or Intolerance to TNF Inhibitors (PR Newswire)
06.11.17	Lilly, Incyte: Baricitinib Shows Greater Improvements In Pain Control In RA (RTTNews)
05.11.17	ACR/ARHP 2017: New Analysis Shows Rheumatoid Arthritis Patients Treated with Baricitinib Reported Greater Improvements in Pain Compared to Adalimumab or Placebo (PR Newswire)
03.11.17	Boyd Group Income Fund Announces Completion of Redemption of Convertible Debentures (PR Newswire)
30.10.17	BMO Blue Book: Provinces in Central Canada See Strengthening Growth, Led by Ontario (PR Newswire)
30.10.17	Lilly to Present New Data on Immunology Portfolio at ACR/ARHP Annual Meeting (PR Newswire)
25.10.17	5 Tenets for Successful Robotic Process Automation Deployment (PR Newswire)
25.10.17	Lilly To Participate In Credit Suisse 26th Annual Healthcare Conference (PR Newswire)
24.10.17	Lilly Lifts FY17 View As Q3 Results Top Estimates; Mulls IPO Or Sale Of Elanco (RTTNews)
24.10.17	Eli Lilly And Co. Q3 Earnings Rise 19% (RTTNews)
24.10.17	Lilly Reports Third-Quarter Results, Announces Strategic Review of Elanco Animal Health (PR Newswire)
23.10.17	Eli Lilly Plans To Invest $72 Mln In Insulin Manufacturing Project - Quick Facts (RTTNews)
23.10.17	Lilly announces $72 million investment in diabetes manufacturing in Indianapolis (PR Newswire)
18.10.17	Lilly and CureVac Announce Global Collaboration to Develop mRNA Cancer Vaccines (PR Newswire)
16.10.17	Lilly Declares Fourth-Quarter 2017 Dividend (PR Newswire)
16.10.17	Eli Lilly: REVEL Data Show Efficacy Of Ramucirumab Plus Docetaxel - Quick Factsz (RTTNews)
16.10.17	Rapidly Progressing Advanced Non-Small Cell Lung Cancer Patients Shown to Benefit in New CYRAMZA® (ramucirumab) Phase 3 Subgroup Analysis (PR Newswire)
14.10.17	Indigenous groups, science community, marine industry, and government partners make progress in protecting endangered killer whale population (PR Newswire)
12.10.17	Lilly's Verzenio Gets FDA Priority Review Designation For Advanced Breast Cancer (RTTNews)
12.10.17	FDA Grants Priority Review for Potential New Indication for Lilly's Verzenio™ (abemaciclib) as Initial Treatment of Advanced Breast Cancer (PR Newswire)
11.10.17	CRY Opens Wallet, LLY's JUNIPER Flops, MDXG Catches Eyes, RNN Awaits DATA In Q4 (RTTNews)
10.10.17	Lilly Reports Topline Results from Phase 3 JUNIPER Trial Evaluating Verzenio™ (abemaciclib) in KRAS-Mutated, Advanced Non-Small Cell Lung Cancer (PR Newswire)
10.10.17	InMed Appoints Dr. Mauro Maccarrone to its Scientific Advisory Board (PR Newswire)
09.10.17	New Drugs Approved In September (RTTNews)
06.10.17	Lilly MONARCH 3 Study Published in Journal of Clinical Oncology Demonstrates Benefit of Verzenio™ (abemaciclib) Plus NSAI in Advanced Breast Cancer (PR Newswire)
06.10.17	SK Planet Japan to Launch Geo-Targeted Crypto-Currencies to Attract Booming Chinese Tourists (PR Newswire)
05.10.17	U.S. Patent and Trademark Office Rules In Lilly's Favor On Alimta Vitamin Regimen Patent (PR Newswire)
05.10.17	Additional Delivery of Insulin Ready for Distribution in Puerto Rico (PR Newswire)
05.10.17	MDA Completes Acquisition of DigitalGlobe, Creates Industry Leader in Satellite Systems, Earth Imagery, Geospatial Solutions and Analytics (PR Newswire)
04.10.17	Humalog® Junior KwikPen® Now Available in the U.S. for People with Diabetes (PR Newswire)
03.10.17	Arbor Pharmaceuticals, LLC & Debiopharm International annoncent la commercialisation de Triptodur™, formulation triptoreline 6 mois, pour le traitement des patients atteints de puberte precoce... (PR Newswire)
02.10.17	NAFTA, retail innovation, brand resilience and entrepreneurial retailer leadership examined on Oct 12 at Retail West 2017 (PR Newswire)
02.10.17	Lilly Confirms Date and Conference Call for Third-Quarter 2017 Financial Results Announcement (PR Newswire)
29.09.17	Lilly Promotes Josh Smiley To SVP And CFO (RTTNews)
29.09.17	Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing (PR Newswire)
29.09.17	FDA Okays Lilly's Breast Cancer Drug Verzenio (RTTNews)
28.09.17	Elanco Celebrates 10 Years of Volunteerism During Global Day of Service (PR Newswire)
25.09.17	Geisinger, Boehringer Ingelheim Announce Collaboration - Quick Facts (RTTNews)
25.09.17	Geisinger and Boehringer Ingelheim collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications,... (PR Newswire)
14.09.17	Lilly Announces New Safety And Efficacy Data From Phase 2 Study Of Baricitinib (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V

mehr

19:12		TELL me! - der Schweizer Trading Podcast: Microsoft unter Kartellverdacht - Novartis auf einem guten Weg - bei Brenntag könnte das zyklische Tief 2025 kommen
17:58		Optimismus in Europa: Euro STOXX 50 zum Ende des Donnerstagshandels in der Gewinnzone
17:58		Freundlicher Handel in Frankfurt: LUS-DAX verbucht schlussendlich Gewinne
17:58		DAX aktuell: DAX zum Handelsende mit Zuschlägen
15:58		Börse Europa: STOXX 50-Börsianer greifen zu
12:26		Gewinne in Europa: STOXX 50 am Mittag mit Kursplus
09:28		Börse Frankfurt in Grün: DAX beginnt Handel im Plus
09:28		Freundlicher Handel in Europa: Euro STOXX 50 zum Start fester

19:12

TELL me! - der Schweizer Trading Podcast: Microsoft unter Kartellverdacht - Novartis auf einem guten Weg - bei Brenntag könnte das zyklische Tief 2025 kommen

17:58

Optimismus in Europa: Euro STOXX 50 zum Ende des Donnerstagshandels in der Gewinnzone

17:58

Freundlicher Handel in Frankfurt: LUS-DAX verbucht schlussendlich Gewinne

17:58

DAX aktuell: DAX zum Handelsende mit Zuschlägen

15:58

Börse Europa: STOXX 50-Börsianer greifen zu

12:26

Gewinne in Europa: STOXX 50 am Mittag mit Kursplus